A5007132745- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- COVID-19 and healthcare impacts
- Intramuscular injections and effects
- Diphtheria, Corynebacterium, and Tetanus
- Veterinary medicine and infectious diseases
- Atrial Fibrillation Management and Outcomes
- COVID-19 diagnosis using AI
- SARS-CoV-2 and COVID-19 Research
Ümraniye Eğitim ve Araştırma Hastanesi
2021-2022
Sağlık Bilimleri Üniversitesi
2021-2022
Introduction: Since the beginning of pandemic, factors associated with mortality in patients corona virus infection disease 2019 (COVID-19) have been investigated. Comorbidities and increased age frequently reported to be mortality. We aimed evaluate unfavorable outcome COVID-19 at an early period pandemic.
 Methodology: This single center, retrospective, observational study was conducted among laboratory confirmed hospitalized between March 11 May 5, 2020, Umraniye Training Research...
As the Modified Anticoagulation and Risk Factors in Atrial Fibrillation Score (M-ATRIA-RS) encompasses prognostic risk factors of novel coronavirus-2019 (COVID-19), it may be used to predict in-hospital mortality. We aimed investigate whether M-ATRIA-RS was an independent predictor mortality patients hospitalized for COVID-19 compare its discrimination capability with CHADS, CHA2DS2-VASc, modified CHA2DS2-VASc (mCHA2DS2-VASc)-RS.A total 1,001 were retrospectively analyzed classified into...
GİRİŞ COVID-19, ilk olarak Aralık 2019'da Çin'in Vuhan şehrinde ortaya çıkmış ve Mart 2020'de Dünya Sağlık Örgütü (DSÖ) tarafından pandemi kabul edilmiştir. Günümüzde 176 milyona yakın doğrulanmış olgu 3.5 milyonu aşkın ölüm ile dünya çapında devam etmektedir (1). COVID-19; ateş, halsizlik, öksürük gibi semptomlarla hafif seyredebileceği solunum desteği ihtiyacına da sebep olan […]
Objective: Interleukin-6 inhibitor Tocilizumab (TCZ) is effective to prevent the mortality of severe COVID-19 by suppressing cytokine storm, however, its appropriate use needs be detailed. We aimed describe TCZ in critical cases with pneumonia early phase pandemic.
Objective: Our country has limited data on protective antibody levels following primary tetanus immunization. In this study, we planned to evaluate the seroprevalence of healthcare workers in our hospital according age and occupational groups. Methods: Tetanus were determined by enzyme-linked immunosorbent assay (ELISA) method. Antibody results obtained through operating system, level ≥0.5 IU/mL was considered seropositive. Results: 77.5% 2082 According groups, highest seropositivity between...